ADDITIVE MANUFACTURING SOLUTIONS FOR
NANO AND MICRO FIBROUS MATRIXES IN
BIOMEDICAL AND BIOPHARMACEUTICAL APPLICATIONS
Our core technology combines solvent-free and solvent-based electrospinning processes with additive manufacturing (3D printing).
Why work with us
Volatile Innovation has received support from the Agency for Science, Innovation and Technology (MITA) for the commercialization of therapeutic cosmetic products with bioactive substances in hydrocolloid matrixes utilising technological opportunities provided by 3D fibre printing technology.
The total budget for the 15 months project is EUR 100 000, to be completed in October of 2021.